NEMOZOLE CHEWABLE PILLS 400MG
NEMOZOLE CHEWABLE PILLS 400MG - 1TAB
Security policy (edit with Customer reassurance module)
Delivery policy (edit with Customer reassurance module)
Return policy (edit with Customer reassurance module)
- nematodoses (ascariasis, enterobiosis, ankilostomidoz, nekatorosis, trichocephalosis);
- mixed helminthic invasions;
- neurocysticercosis caused by the larval form of Taenia solium;
- Echinococcosis of the liver, lungs, peritoneum, caused by the larval form of Echinococcus granulosus;
- as an aid in the surgical treatment of echinococcosis cysts.
The average therapeutic dose for treatment of nematodosis for adults and children over 2 years old makes 400 mg or 20 ml of suspension inside once.
The drug is taken during the meal. It is recommended that simultaneous treatment of all family members.
At neurocysticercosis and echinococcosis for patients weighing 60 kg or more the drug is prescribed 400 mg 2 times / day; weighing less than 60 kg The dose is established at the rate of 15 mg / kg / day in 2 doses. The maximum daily dose is 800 mg (400 mg 2 times / day). The course of treatment for neurocysticercosis - 8-30 days; at echinococcosis - 3 cycles of 28 days with a 14-day interval between cycles.
At giardiasis for children the drug is prescribed at the rate of 10-15 mg / kg 1 time / day for 5-7 days.
At toxocarosis adults and children over 14 years old weighing over 60 kg appoint 400 mg 2 times / day; weighing less than 60 kg - 200 mg 2 times / day; children under 14 dose set at the rate of 10 mg / kg 2 times / day. Duration of therapy is 7-14 days.
Gastrointestinal: abnormal liver function with changes in functional liver tests (mild or moderate increase in transaminase activity), abdominal pain, nausea, vomiting.
Hemic and lymphatic: leukopenia, granulocytopenia, agranulocytosis, thrombocytopenia, pancytopenia.
From the side of the central nervous system: headache, dizziness, meningeal symptoms.
Dermatologic: reversible alopecia, skin rash, itching.
Other: fever, increased blood pressure, acute renal failure, allergic reactions.
- damage to the retina;
- Hypersensitivity to the components of the drug and other benzimidazole derivatives.
WITH caution used in violation of blood, abnormal liver function (before and during treatment should regularly monitor liver function) during breastfeeding.
Use during pregnancy and lactation
The drug is contraindicated for use in pregnancy. If necessary, the appointment of the drug during lactation should decide on the termination of breastfeeding.
Before the appointment of the drug should be tested for the absence of pregnancy in women of childbearing age. During the period of therapy should use reliable methods of contraception.
Application for violations of the liver
WITH caution used for violations of the liver (before and during treatment should regularly monitor liver function).
Use in children
Perhaps the use of indications and doses, taking into account the age of patients.
With neurocysticercosis, appropriate therapy of corticosteroids and anticonvulsants should be carried out. GCS for oral or IV administration is used to prevent a hypertensive attack in the first week of anti-cystic therapy.
Control of laboratory parameters
Against the background of the drug is recommended to control the cellular composition of blood. If leukopenia occurs, therapy is suspended.
Blood tests should be carried out at the beginning of each 28-day cycle every 2 weeks during the period of treatment with albendazole. It is possible to continue treatment with albendazole if the decrease in the total content of leukocytes and neutrophil leukocytes is moderate and does not progress.
Treatment: gastric lavage, Activated carbon. If necessary, conduct symptomatic therapy.
When combined with albendazole, Dexamethasone and cimetidine increase the concentration of albendazole sulfoxide in the blood.
Terms and conditions of storage
List B. The drug should be kept out of the reach of children, dry, protected from light, at a temperature not exceeding 25 ° C.